Back to RA CAPITAL MANAGEMENT, L.P.

ABOS
Showing 8 of 19 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in ACUMEN PHARMACEUTICALS INC

RA CAPITAL MANAGEMENT, L.P. holds 21M shares of ABOS (ACUMEN PHARMACEUTICALS INC), worth $49.5M as of 2026-Q1. The position was increased (+40.6% shares). ABOS represents 0.5% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$49.5M

Current Shares

21M

Total Value Change

+$13.4M

Total Shares Change

+6.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
21M
+40.6%
$49.5M0.5%$3.31
55
2025-Q4
Unchanged
14.9M
0.0%
$31.5M0.3%$2.00
0
2025-Q3
Unchanged
14.9M
0.0%
$25.5M0.3%$1.58
0
2025-Q2
Unchanged
14.9M
0.0%
$17.3M0.3%$1.12
0
2025-Q1
Unchanged
14.9M
0.0%
$16.4M0.3%$1.19
0
2024-Q4
Unchanged
14.9M
0.0%
$25.7M0.3%$1.75
0
2024-Q3
Unchanged
14.9M
0.0%
$37M0.4%$2.48
0
2024-Q2
Unchanged
14.9M
0.0%
$36.1M0.5%$2.42
0

Other major holders of ABOS: FRANKLIN RESOURCES INC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used